Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2006-5-15
pubmed:abstractText
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm of the gastrointestinal tract. Surgery has been the only effective therapy. However, many patients still eventually die of disease recurrence. Chemotherapy and radiation therapy have been of limited value. Imatinib mesylate (Glivec) is an orally administered competitive inhibitor of tyrosine kinases associated with the KIT, ABL protein, licensed for the treatment of metastatic GIST since 2002 in Germany.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0257-2753
pubmed:author
pubmed:copyrightInfo
Copyright 2006 S. Karger AG, Basel.
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
207-11
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16699280-Adult, pubmed-meshheading:16699280-Aged, pubmed-meshheading:16699280-Aged, 80 and over, pubmed-meshheading:16699280-Antineoplastic Agents, pubmed-meshheading:16699280-Disease-Free Survival, pubmed-meshheading:16699280-Female, pubmed-meshheading:16699280-Follow-Up Studies, pubmed-meshheading:16699280-Gastrointestinal Stromal Tumors, pubmed-meshheading:16699280-Germany, pubmed-meshheading:16699280-Humans, pubmed-meshheading:16699280-Male, pubmed-meshheading:16699280-Middle Aged, pubmed-meshheading:16699280-Piperazines, pubmed-meshheading:16699280-Protein-Tyrosine Kinases, pubmed-meshheading:16699280-Pyrimidines, pubmed-meshheading:16699280-Retrospective Studies, pubmed-meshheading:16699280-Severity of Illness Index, pubmed-meshheading:16699280-Survival Rate, pubmed-meshheading:16699280-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg.
pubmed:affiliation
Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. Bernd_Kasper@med.uni-heidelberg.de
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't